Literature DB >> 24591551

Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women.

Elisabeth Lerchbaum1, Verena Schwetz, Albrecht Giuliani, Barbara Obermayer-Pietsch.   

Abstract

OBJECTIVE: There is evidence suggesting a strong genetic background of polycystic ovary syndrome (PCOS). We aim to study the metabolic and endocrine characteristics of PCOS women with and without a family history (FHx) of type 2 diabetes mellitus (T2DM) and PCOS.
DESIGN: Cross-sectional study.
METHODS: We analysed the association of T2DM FHx and PCOS FHx with metabolic and endocrine parameters in 714 PCOS women.
RESULTS: A positive FHx of T2DM and PCOS were prevalent in 36.8 and 21.4% of PCOS women respectively. We found an independent association of T2DM FHx with central fat accumulation, obesity, prediabetes, metabolic syndrome (MS), insulin resistance, low HDL and elevated blood pressure (P<0.05 for all). PCOS FHx was independently associated with prediabetes (P<0.05). We observed an independent association of PCOS FHx with clinical and biochemical hyperandrogenism (P<0.05 for all), whereas there was no independent association of T2DM FHx with hyperandrogenism. PCOS women with a positive FHx of both T2DM and PCOS had an adverse metabolic and endocrine profile including a linear increase in risk of obesity, central fat accumulation, MS, prediabetes and low HDL (P<0.05 for all).
CONCLUSIONS: Our findings suggest that the assessment of FHx might allow risk stratification of PCOS women, which is important considering the high prevalence of PCOS.

Entities:  

Mesh:

Year:  2014        PMID: 24591551     DOI: 10.1530/EJE-13-1035

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

Review 1.  PCOS in adolescence and type 2 diabetes.

Authors:  Anne-Marie Carreau; Jean-Patrice Baillargeon
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

2.  Paternal history of diabetes mellitus and hypertension affects the prevalence and phenotype of PCOS.

Authors:  Chen Cheng; Haolin Zhang; Yue Zhao; Rong Li; Jie Qiao
Journal:  J Assist Reprod Genet       Date:  2015-10-06       Impact factor: 3.412

3.  Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.

Authors:  Zelija Velija-Asimi; Azra Burekovic; Tanja Dujic; Amela Dizdarevic-Bostandzic; Sabina Semiz
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

4.  Family history of menstrual irregularity or diabetes mellitus enhances the susceptibility to polycystic ovary syndrome among subjects harboring rs7903146 genetic variant of TCF7L2.

Authors:  Rabiya Rashid; Idrees A Shah; Mir M Asrar; Meena Godha; Bashir A Ganai; Mohd Ashraf Ganie
Journal:  J Diabetes Metab Disord       Date:  2022-05-17

5.  Endocrinological and metabolic characteristics in patients who are non-obese and have polycystic ovary syndrome and different types of a family history of type 2 diabetes mellitus.

Authors:  Yuan Wang; Hua Gao; Wen Di; Zhuowei Gu
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome.

Authors:  Karoon Shahebrahimi; Nasrin Jalilian; Nasrin Bazgir; Mansour Rezaei
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

7.  UPLC/Q‑TOF‑MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome.

Authors:  Xuemei Fan; Jianfa Jiang; Zhiqiang Huang; Jumei Gong; Yiming Wang; Wei Xue; Yan Deng; Yanfang Wang; Tingping Zheng; Aijun Sun; Guoan Luo
Journal:  Mol Med Rep       Date:  2018-11-12       Impact factor: 2.952

8.  Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome.

Authors:  Havagiray R Chitme; Eman A K Al Azawi; Anfal M Al Abri; Buthina M Al Busaidi; Zamzam K A Salam; Maisa M Al Taie; Saja K Al Harbo
Journal:  J Taibah Univ Med Sci       Date:  2017-01-13

9.  Effect of Metformin-sustained Release Therapy on Low-density Lipoprotein Size and Adiponectin in the South Indian Women with Polycystic Ovary Syndrome.

Authors:  D Rama Nagendra Kumar; Krishna G Seshadri; Monna Pandurangi
Journal:  Indian J Endocrinol Metab       Date:  2017 Sep-Oct

10.  The Role of GnRH Receptor Autoantibodies in Polycystic Ovary Syndrome.

Authors:  David C Kem; Hongliang Li; Xichun Yu; Elizabeth Weedin; Anna C Reynolds; Elizabeth Forsythe; Marci Beel; Hayley Fischer; Brendon Hines; Yankai Guo; Jielin Deng; Jonathan T Liles; Zachary Nuss; Myriam Elkosseifi; Christopher E Aston; Heather R Burks; LaTasha B Craig
Journal:  J Endocr Soc       Date:  2020-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.